Details of the Drug Formulaction

General Information of Drug Formulation (ID: F08039)

Formulation Name
Fenofibrate 48 mg tablet
Company
Avera McKennan Hospital; NuCare Pharmaceuticals; Zydus Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Fenofibrate DMFKXDY Coronary atherosclerosis Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Crospovidone E00626 Not Available Disintegrant
Docusate sodium E00563 23673837 Surfactant
FD&C blue no. 2 E00446 2723854 Colorant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Quinoline yellow WS E00309 24671 Colorant
Saccharose E00091 5988 Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Soybean lecithin E00637 Not Available Other agent
Sunset yellow FCF E00255 17730 Colorant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent